GUERRA, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 8.328
AS - Asia 4.255
EU - Europa 4.042
SA - Sud America 661
AF - Africa 62
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 17.363
Nazione #
US - Stati Uniti d'America 8.115
SG - Singapore 1.293
IT - Italia 1.115
VN - Vietnam 1.084
CN - Cina 984
DE - Germania 623
RU - Federazione Russa 583
BR - Brasile 546
HK - Hong Kong 515
SE - Svezia 463
IE - Irlanda 345
GB - Regno Unito 214
UA - Ucraina 197
CA - Canada 160
IN - India 93
FR - Francia 91
FI - Finlandia 85
AT - Austria 80
DK - Danimarca 59
AR - Argentina 46
KR - Corea 42
JP - Giappone 39
MX - Messico 38
NL - Olanda 36
PL - Polonia 36
TR - Turchia 35
BD - Bangladesh 33
ID - Indonesia 31
IQ - Iraq 28
BE - Belgio 27
EC - Ecuador 25
ZA - Sudafrica 25
ES - Italia 19
CZ - Repubblica Ceca 18
BG - Bulgaria 15
KE - Kenya 11
VE - Venezuela 11
PK - Pakistan 10
CH - Svizzera 8
IR - Iran 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
SA - Arabia Saudita 7
PE - Perù 6
RO - Romania 6
TN - Tunisia 6
UY - Uruguay 6
AU - Australia 5
CL - Cile 5
EU - Europa 5
IL - Israele 5
KG - Kirghizistan 5
MA - Marocco 5
UZ - Uzbekistan 5
DZ - Algeria 4
EG - Egitto 4
JO - Giordania 4
LT - Lituania 4
OM - Oman 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
LK - Sri Lanka 3
MK - Macedonia 3
NI - Nicaragua 3
AL - Albania 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
MY - Malesia 2
NP - Nepal 2
PH - Filippine 2
SC - Seychelles 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
GD - Grenada 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
PA - Panama 1
RE - Reunion 1
RS - Serbia 1
SN - Senegal 1
Totale 17.360
Città #
Ann Arbor 1.819
Singapore 857
Ashburn 730
Fairfield 557
Hong Kong 504
Woodbridge 461
Chandler 444
Houston 401
Wilmington 397
Milan 355
Ho Chi Minh City 338
Dublin 332
Frankfurt am Main 320
Dearborn 248
Hanoi 240
Seattle 235
New York 217
Jacksonville 199
Cambridge 177
Santa Clara 175
Beijing 159
Los Angeles 138
Princeton 134
Dallas 117
Lissone 104
Shanghai 103
Hefei 89
Nanjing 76
The Dalles 73
Vienna 63
Lawrence 61
São Paulo 59
Altamura 52
Moscow 49
Munich 49
Guangzhou 46
Buffalo 44
Chicago 44
Falls Church 43
San Diego 42
London 40
Da Nang 38
Fremont 38
Seoul 37
Helsinki 35
Tokyo 33
Lachine 30
Shenyang 29
Boardman 28
Jinan 28
Council Bluffs 27
Nanchang 27
Warsaw 27
Dong Ket 26
Montreal 25
Toronto 25
Haiphong 24
Brussels 23
Jakarta 23
Poplar 23
Monza 22
Ha Long 21
Hải Dương 21
Nuremberg 21
Ottawa 21
Thái Nguyên 20
Vancouver 20
Bắc Ninh 19
Andover 18
Biên Hòa 18
Brooklyn 18
Chennai 17
Hebei 17
Vũng Tàu 17
Ninh Bình 16
Segrate 16
Genoa 15
Kunming 15
Rio de Janeiro 15
Salt Lake City 15
Boston 14
Brno 14
Bắc Giang 14
Manchester 14
Turku 14
Atlanta 13
Bari 13
Columbus 13
Johannesburg 13
Orem 13
Plovdiv 13
Pune 13
Stockholm 13
Tampa 13
Amsterdam 12
Edmonton 12
Quận Bình Thạnh 12
Tianjin 12
Rome 11
Brasília 10
Totale 11.755
Nome #
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 687
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 471
18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor? 437
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 409
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 400
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 380
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 375
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 367
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 345
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 315
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 312
Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results 309
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 304
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 302
Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT 302
Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer 297
Respiratory motion management in PET/CT: applications and clinical usefulness 297
Motion management in PET/CT: Technological solutions 291
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 289
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 284
Erratum: ☆Corrigendum to “Recommendations for surveillance and follow-up of men with testicular germ cell tumors: A multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica” (Critical Reviews in Oncology / Hematology (2019) 137 (154–164), (S1040842819300587), (10.1016/j.critrevonc.2019.03.006)) 279
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 277
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 269
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 268
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 265
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica 262
Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study 258
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 258
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 258
Intracavitary Brachytherapy in Cervical Carcinoma: The Role of F18-FDGPET in Treatment Planning 253
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 251
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 251
Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination 247
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients 247
Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer 246
Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study 243
Validity of cingulate–precuneus–temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer’s Disease 242
Lung Regional Metabolic Activity and Gas Volume Changes Induced by Tidal Ventilation in Patients with Acute Lung Injury 234
Radiolabeled fibroblast activation protein inhibitor (FAPI) PET in oncology: has the time come for 18F-fluorodeoxyglucose to think to a well-deserved retirement? 224
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 223
A case of Melas (A3243G) on chronic dichloroacetate treatment 216
Imaging of lung inflammation during severe influenza A: H1N1 212
Italian Multicenter Study on Accuracy of 18 F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma 212
Focal bone lesions in hiv-positive patient treated with tenofovir 209
Performance measurements for the PET/CT Discovery-600 using NEMA NU 2-2007 standards 205
Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions 204
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 201
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 201
Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: Detection of pelvic nodal metastases 197
Tidal changes on CT and progression of ARDS 191
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 191
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 188
FDG PET in response evaluation of bulky masses in paediatric Hodgkin’s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial 188
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 187
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 183
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial 180
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study 174
Comment on 'Pre-operative nomogram for the identification of lymph node metastasis in early cervical cancer' 165
The need of a clinically oriented reporting of 18F-FDG PET/CT in non-small cell lung cancer (NSCLC) 160
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 158
Performance of a SPECT collimator-detector response reconstruction algorithm: phantom studies and validation in inflammation clinical studies 147
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial 138
Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin's disease 137
Respiratory Gating and the performance of PET/CT in pulmonary lesions 137
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation 133
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial 132
The 68Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma) 121
Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial 111
Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial 104
Prognostic value of PET-CT after fi rst-line therapy in patients with follicular lymphoma: A pooled analysis of central scan review in three multicentre studies 96
Hairy cell leukemia with an atypical extranodal presentation: A clinicopathological analysis of four cases 95
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi 90
Immunoscintigraphy of ovarian cancer recurrences: comparison with surgical findings and CT scan or US results 88
Predictive value of pre-treatment FDG PET in patients with non-Hodgkin lymphoma treated with radioimmunotherapy: a systematic review 83
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial 80
Current status of FDG-PET/CT in staging of adult lymphoma 76
Is there a role for metabolic imaging in pediatric non-Hodgkin lymphoma? 51
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT 22
Totale 17.891
Categoria #
all - tutte 56.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.757


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.319 0 0 0 0 0 195 178 231 171 199 150 195
2021/20221.250 140 159 142 109 69 81 68 57 54 117 98 156
2022/20231.791 180 513 168 199 100 276 9 112 121 52 42 19
2023/20241.211 38 40 58 59 140 309 253 56 77 20 13 148
2024/20252.834 145 338 207 119 196 150 195 111 235 462 248 428
2025/20264.590 1.480 548 617 880 952 113 0 0 0 0 0 0
Totale 17.891